Explore Daily Deals Shop with ExpertBuy Again Orders Help & Support

Medical Supplies

About Us

What Makes Us Different?

Our Core Values

Our Testimonials

Our Culture

How Reliable Are We?

Providing Cutting Edge Solution Globally

Partner With USA MedPremium

Healthcare Professional Statement

Quality Assurance

Our Service & Solutions

Analytics & Reporting

Inventory Management

Distribution Solutions

Streamline Integration

Cost Effective Healthcare solutions

Supply Chain Optimization

Credit Allocation

Customer Service

Live Chat Support

Shipping & Returns

Terms & Conditions

Account

Forgot Password

LegitScript CertifiedVerified Healthcare Distributor

Follow us:

©2026 USA MedPremium. All rights reserved.

Do Not Sell My Information

Cookies Preference

Pharmaceutical Licensing

Do Not Sell My InformationDo Not Sell My Information

Cookies PreferenceCookies Preference

Terms of UseTerms of Use

Site MapSite Map

Pharmaceutical LicensingPharmaceutical Licensing

Takeda Pharmaceuticals America Inc 64764010821 - … | USA MedPremium

Home
All Products
Categories
Rx Prescriptions
Immunosuppressive Agents
Integrin Receptor Antagonist

ENTYVIO® Vedolizumab 108 mg / 0.68 mL Injection Prefilled Injection Pen

USAMP#19473154SKU: 64764010821ENTYVIO®

License Required

productImage

productImage

productImage

productImage

Product Spotlight

ENTYVIO is an integrin receptor antagonist indicated in adults for the treatment of: moderately to severely active ulcerative colitis and moderately to severely active Crohn's disease

Frequently Bought Together